CAH
44
7
GD
42
4
FOXA
67
5
CLX
65
2
ALL
37
3
GOOG
77
14
EQT
47
13
QRVO
16
-6
IVZ
42
13
BF.B
35
2
VRSK
54
2
ROK
46
3
AZO
46
3
ED
39
8
SYF
78
7
ORCL
49
3
CI
35
2
CTAS
36
8
BAC
38
3
AA
27
5
CAH
44
7
GD
42
4
FOXA
67
5
CLX
65
2
ALL
37
3
GOOG
77
14
EQT
47
13
QRVO
16
-6
IVZ
42
13
BF.B
35
2
VRSK
54
2
ROK
46
3
AZO
46
3
ED
39
8
SYF
78
7
ORCL
49
3
CI
35
2
CTAS
36
8
BAC
38
3
AA
27
5
Financhill
Back

Syros Pharmaceuticals 10K Form

Sell
25

SYRS
Syros Pharmaceuticals

Last Price:
$0.21
Seasonality Move:
5.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SYRS News And Ratings

See the #1 stock for the next 7 days that we like better than SYRS

SYRS Financial Statistics

Sales & Book Value

Annual Sales: $9.9M
Cash Flow: $-20.7M
Price / Cash Flow: 0
Annual Sales: $-0.41
Price / Book: 8.06

Profitability

EPS (TTM): -3.07000
Net Income (TTM): $-97.8M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Syros Pharmaceuticals Earnings Forecast

Key Syros Pharmaceuticals Financial Ratios

  • The Research & Development expenses have been 1,088.50% of Revenue.
  • The Interest Expense is -3.12% of Operating Income.
  • The Net Earning history of SYRS is -1,656.34% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 8 years.

Syros Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SYRS
CUSIP: 87184Q
Website: syros.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SYRS Technical Analysis vs Fundamental Analysis

Sell
25
Syros Pharmaceuticals (SYRS) is a Sell

Is Syros Pharmaceuticals a Buy or a Sell?